CELYAD ONCOLOGY Slumps 9% As Market Ends Session: Is Trouble Brewing?
(VIANEWS) – CELYAD ONCOLOGY (BEL 20: CYAD.BR) fell 9.81% to EUR0.96 at 15:18 EST Monday afternoon after four straight sessions of gains, while the BEL 20 was down 0.35% at EUR3,670.13, signalling an overall downward trend for today’s trading session. About CELYAD ONCOLOGY Celyad Oncology SA is a clinical-stage biopharmaceutical company focused on the research…